Last updated: August 14, 2023
Sponsor: University of Colorado, Denver
Overall Status: Active - Not Recruiting
Phase
1/2
Condition
Stress
Diabetes Prevention
Diabetes And Hypertension
Treatment
Iohexol Inj 300 MG/ML
Aminohippurate Sodium Inj 20%
Renal Biopsy
Clinical Study ID
NCT03584217
16-1752
Ages 12-21 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Obese youth with and without T2D (≥54 kg) and lean controls
- Age 12-21 years
- Weight <300 lbs., no implanted metal devices
- HbA1c < 11% and no recent diabetic ketoacidosis or hyperosmolar hyperglycemia
- No anemia
- BMI >5th percentile for lean controls
Exclusion
Exclusion Criteria:
- T2D onset (diagnosis) > 18 years of age
- Prepubertal
- eGFR <60ml/min/1.73m2 or creatinine > 1.5mg/dl or history of ACR≥300mg/g
- ACE inhibitors, angiotensin receptor blockers (ARB), diuretics, sodium-glucoseco-transport (SGLT) 2 or 1 blockers, daily NSAIDs or aspirin, sulfonamides, procaine,thiazosulfone or probenecid.
- Seafood or iodine allergy
- Pregnancy
- MRI scanning contraindications (claustrophobia, implantable devices, >300 lbs) Additional exclusion criteria for participants undergoing optional kidney biopsy:
- Evidence of bleeding disorder or complications from bleeding
- Use of aspirin, NSAIDS or other blood thinner that cannot be safely stopped for asufficient time period before and after the biopsy so as to add no additional risk ofbleeding
- Blood urea nitrogen (BUN) > 80 gm/dL
- INR > 1.4
- PTT > 35 seconds
- Hemoglobin (Hgb) < 10 mg/dL
- Platelet count < 100,000 / µL
- Uncontrolled or difficult to control hypertension (> 150/90 mmHg at the day of biopsy)
- eGFR < 40 mL/min/1.73m2
- Single kidney (either by history, documented by prior imaging or ultrasound performedprior to the biopsy)
- > 2 cm discrepancy between left and right kidney sizes based on largest longitudinaldiameter determined by ultrasound performed prior to the biopsy.
- Kidney size: One or both kidneys < 9 cm
- Hydronephrosis or other important renal ultrasound findings such as significant stonedisease
- Any evidence of a current urinary tract infection as indicated on day of biopsy
- Clinical evidence of non-diabetic renal disease
- Positive urine pregnancy test or pregnancy
Study Design
Total Participants: 100
Treatment Group(s): 3
Primary Treatment: Iohexol Inj 300 MG/ML
Phase: 1/2
Study Start date:
October 01, 2018
Estimated Completion Date:
October 30, 2023
Connect with a study center
Children's Hospital Colorado
Aurora, Colorado 80238
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.